Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)

Direct Payment

$105,000.00

Chemical screen for modulators of hematopoietic stem cell expansion using zebrafish embryo cultures

EF 2015-16

Résumé
Blood stem cells help support and replenish the blood system by producing all types of blood cells. When blood stem cells are damaged or diseased, a person may need a bone marrow transplant. Unfortunately, nearly half of all patients do not have an optimally matched donor marrow. One potential therapy for these patients involves taking any type of their own adult cells (such as skin cells) and reprogramming them to an earlier embryonic-like state. These reprogrammed "pluripotent" cells can give rise to cells that can then be manipulated to mature into healthy blood stem cells. In this way, a patient's own cells can be used to generate the blood cells needed, which ensures that the transplanted cells are a perfect match. However, the steps needed to convert a pluripotent cell into a blood stem cell are not fully known. To address this, I have developed a screening system that uses cells from zebrafish embryos. The zebrafish were engineered to have fluorescent genes that mark different stages of blood stem cell development in the embryo. This enables me to screen for chemicals that promote blood stem cell formation from pluripotent cells. Since zebrafish have many genes in common with mammals, including humans, chemicals that we find in our zebrafish screen can be reliably translated to mammalian settings. These chemicals may be used to establish more efficient ways to generate blood stem cells from human pluripotent sources, which would be transformative for personalized regeneration therapies to treat blood-related diseases and disorders.
Programme
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
347881
Name
Mandelbaum Joseph
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Chemical screen for modulators of hematopoietic stem cell expansion using zebrafish embryo cultures
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Bone Marrow Transplant; Chemical Screening; Embryo Cultures; Hematopoiesis; Hematopoietic Stem Cells; Regeneration; Stem Cell Differentiation; Stem Cell Expansion; Zebrafish
Abstract
Blood stem cells help support and replenish the blood system by producing all types of blood cells. When blood stem cells are damaged or diseased, a person may need a bone marrow transplant. Unfortunately, nearly half of all patients do not have an optimally matched donor marrow. One potential therapy for these patients involves taking any type of their own adult cells (such as skin cells) and reprogramming them to an earlier embryonic-like state. These reprogrammed "pluripotent" cells can give rise to cells that can then be manipulated to mature into healthy blood stem cells. In this way, a patient's own cells can be used to generate the blood cells needed, which ensures that the transplanted cells are a perfect match. However, the steps needed to convert a pluripotent cell into a blood stem cell are not fully known. To address this, I have developed a screening system that uses cells from zebrafish embryos. The zebrafish were engineered to have fluorescent genes that mark different stages of blood stem cell development in the embryo. This enables me to screen for chemicals that promote blood stem cell formation from pluripotent cells. Since zebrafish have many genes in common with mammals, including humans, chemicals that we find in our zebrafish screen can be reliably translated to mammalian settings. These chemicals may be used to establish more efficient ways to generate blood stem cells from human pluripotent sources, which would be transformative for personalized regeneration therapies to treat blood-related diseases and disorders.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mandelbaum, Joseph
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~